Trial Profile
Phase II study of bevacizumab for the treatment of vascular tumours in children [TRATAMIENTO DE LOS TUMORES VASCULARES DEL DESARROLLO CON BEVACIZUMAB A PHASE II STUDY OF BEVACIZUMAB FOR VASCULAR TUMORS OF CHILDHOOD]
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Aug 2011
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Cancer
- Focus Biomarker; Therapeutic Use
- 26 Aug 2011 New trial record